Overview
Hana Raslova practices practicing medicine in Villejuif, France.
Ms. Raslova is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Acute Megakaryoblastic Leukemia, RUNX1 Familial Platelet Disorder, Bernard-Soulier Syndrome, and Essential Thrombocythemia.
She is actively involved in clinical research, co-authoring 74 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hana Raslova
Is Hana Raslova a top-rated expert for Acute Megakaryoblastic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Hana Raslova is classified as an Distinguished expert for Acute Megakaryoblastic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hana Raslova participate in research or clinical trials?
Yes. Hana Raslova has published 74 articles and abstracts on conditions like Acute Megakaryoblastic Leukemia. You can view a list of Hana Raslova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Megakaryoblastic LeukemiaMs. Raslova isDistinguished. Learn about Acute Megakaryoblastic Leukemia.
- Bernard-Soulier SyndromeMs. Raslova isDistinguished. Learn about Bernard-Soulier Syndrome.
- Essential ThrombocythemiaMs. Raslova isDistinguished. Learn about Essential Thrombocythemia.
- RUNX1 Familial Platelet DisorderMs. Raslova isDistinguished. Learn about RUNX1 Familial Platelet Disorder.
- Advanced
- Acute Myeloid Leukemia (AML)Ms. Raslova isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Blood ClotsMs. Raslova isAdvanced. Learn about Blood Clots.
- MyelofibrosisMs. Raslova isAdvanced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Ms. Raslova isAdvanced. Learn about Myeloproliferative Neoplasms (MPN).
- ThrombocytopeniaMs. Raslova isAdvanced. Learn about Thrombocytopenia.
- Experienced
- Acquired Amegakaryocytic ThrombocytopeniaMs. Raslova isExperienced. Learn about Acquired Amegakaryocytic Thrombocytopenia.
- AnemiaMs. Raslova isExperienced. Learn about Anemia.
- Hearing LossMs. Raslova isExperienced. Learn about Hearing Loss.
- LeukemiaMs. Raslova isExperienced. Learn about Leukemia.
- MYH9 Related ThrombocytopeniaMs. Raslova isExperienced. Learn about MYH9 Related Thrombocytopenia.
- Polycythemia VeraMs. Raslova isExperienced. Learn about Polycythemia Vera.